论文信息 - Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study. - 字舞流文

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study.

M. Williams | S. Fosså | D. Dearnaley | S. Kaye | J. Graham | G. Mead | S. Harland | M. Cullen | P. Cook | S. Stenning | M. Sokal | J. Roberts | F. Madden | Tmrcttwp for